Arthur Brothag

Industry experience:Country:United KingdomOffice:LondonJoined Apax:

2009

Arthur Brothag 

Experience and qualifications

Arthur Brothag is a Principal and joined Apax Partners in 2009. He is a member of the Healthcare team and is based in the London office. Arthur has participated in a number of key deals, including Acelity (formerly known as KCI), Unilabs and EVRY. He is serving as a Board member of Unilabs and as an Observer on the Acelity (KCI) board.

Prior to joining Apax, Arthur worked at the private equity firm Warburg Pincus in London, where he focused on European healthcare. Before that, he was a member of Morgan Stanley's healthcare M&A team in London.

Arthur trained as a medical doctor with a state diploma and a doctorate from the Technical University of Munich; he held resident positions at University hospitals in Germany and Switzerland in internal medicine (cardiology and oncology). In addition to his medical and research training, he also completed his MBA studies with distinction at INSEAD Business School.

Investments

Investments include:

Acelity

Leading provider of therapies and products for the advanced wound care, tissue regeneration and therapeutic support system markets

EVRY ASA

Leading Nordic IT services business

Unilabs

Leading European laboratory and radiology service Company

Current directorships

Acelity

Leading provider of therapies and products for the advanced wound care, tissue regeneration and therapeutic support system markets

Unilabs

Leading European laboratory and radiology service Company

Find a team member

Want to get in touch with us to find out more?

Visit the London office in contact us